USPTO filed trademark application TM99192492 for 'NELKARMI' on May 19, 2025. The trademark covers pharmaceutical preparations and products for use in oncology diseases and disorders. The application is filed under Intent-to-Use basis, requiring the applicant to demonstrate actual commercial use of the mark within three years of publication.

No immediate action is required from competitors or industry participants. Trademark applications are public record and available for opposition proceedings. Companies developing similar oncology pharmaceutical products may wish to review the application for potential conflicts with existing or planned trademarks. The Intent-to-Use deadline of March 31, 2026 applies to the applicant only.